Lantern Pharma (LTRN) Earnings Analysis
Lantern Pharma (LTRN) next reports earnings on 2026-08-12, consensus EPS -0.38 USD. Last quarter (2026-05-15) it beat with EPS -0.3 USD vs -0.36 USD est (+16.7%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E -1.96.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LTRN next report earnings?
| Next earnings date | 2026-08-12 |
|---|---|
| Consensus EPS estimate | -0.38 USD |
| Revenue estimate | n/a |
LTRN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.3 USD | -0.36 USD | +16.7% | Beat |
| 2026-03-30 | -0.36 USD | -0.46 USD | +21.7% | Beat |
| 2025-08-13 | -0.4 USD | -0.53 USD | +24.5% | Beat |
| 2025-05-15 | -0.42 USD | -0.49 USD | +14.3% | Beat |
| 2024-11-07 | -0.42 USD | -0.56 USD | +25% | Beat |
| 2024-08-08 | -0.46 USD | -0.55 USD | +16.4% | Beat |
Beat rate: 6/6 (100%) over reported quarters with consensus data.
LTRN valuation and analyst view
| Trailing P/E | -1.96 |
|---|---|
| Trailing EPS | -1.414 USD |
| Price / book | 9.27 |
| Dividend yield | 0.00% |
| Market cap | 0.04B |
| Analyst consensus | Buy (2 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Lantern Pharma (LTRN)'s next earnings date?
Lantern Pharma is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.38 USD.
Did LTRN beat earnings last quarter?
In its 2026-05-15 report, LTRN posted EPS of -0.3 USD versus a -0.36 USD estimate — a beat of 16.7%.
What is LTRN's earnings track record?
Over the last 6 reported quarters with consensus data, LTRN beat estimates 6 times (100%).
What is LTRN's current P/E ratio and EPS?
LTRN trades at a trailing P/E of -1.96 on trailing EPS of -1.414003695004812 USD.
What do analysts rate LTRN?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell).